Search company, investor...

Founded Year



Incubator/Accelerator | Alive

About Welch Allyn

Welch Allyn manufactures medical diagnostic equipment. The company's product categories include physical assessment, vital signs monitoring, diagnostic cardiopulmonary, and thermometry. It was founded in 1915 and is based in Skaneateles Falls, New York. Welch Allyn was acquired by Hillrom.

Headquarters Location

4341 State Street Road

Skaneateles Falls, New York, 13153,

United States

+44 (0)20 7365 6780



Expert Collections containing Welch Allyn

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Welch Allyn is included in 2 Expert Collections, including Digital Health.


Digital Health

10,804 items

The digital health collection includes vendors developing software, platforms, sensor & robotic hardware, health data infrastructure, and tech-enabled services in healthcare. The list excludes pureplay pharma/biopharma, sequencing instruments, gene editing, and assistive tech.



2,856 items

Companies developing, offering, or using electronic and telecommunication technologies to facilitate the delivery of health & wellness services from a distance. *Columns updated as regularly as possible; priority given to companies with the most and/or most recent funding.

Welch Allyn Patents

Welch Allyn has filed 579 patents.

The 3 most popular patent topics include:

  • ophthalmology
  • medical equipment
  • optical devices
patents chart

Application Date

Grant Date


Related Topics





Application Date


Grant Date



Related Topics



Latest Welch Allyn News

Global Spirometer Market Size To Exceed USD 3.2 Billion By 2032 | CAGR Of 11.2%

Jan 22, 2024

2032 | CAGR Of 11.2% The Global Spirometer Market Size was valued at USD 1.1 Billion in 2022 and the Worldwide Spirometer Market Size is expected to reach USD 3.2 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Medical International Research (MIR), Morgan Scientific, COSMED srl, Ganshorn Medizin Electronic GmbH, ndd Medizintechnik AG, VYAIRE, MGC Diagnostics Corporation, nSpire Health Inc., Welch Allyn, Sibelmed, Schiller, SDI Diagnostics, Smiths Medical and Others. January 22, 2024 09:30 ET SPHERICAL INSIGHTS LLP New York, United States, Jan. 22, 2024 (GLOBE NEWSWIRE) -- The Spirometer Market Size is to Grow from USD 1.1 Billion in 2022 to USD 3.2 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 11.2% during the projected period. An increase in the number of regulations encouraging the use of spirometer devices, as well as an increase in research funding in developing countries, are expected to provide lucrative opportunities for the spirometer market in the future. Get a Sample PDF Brochure: Spirometry is an ordinary test that determines how well an individual's lungs work by measuring how much air they inhale and expel. It aids in the identification of respiratory illnesses such as asthma, chronic obstructive pulmonary disease (COPD), and others. The test uses a spirometer to assess lung condition and determine whether or not a chronic lung condition treatment is effective. Furthermore, governmental and private sectors are collaborating to develop devices for controlling and diagnosing respiratory illnesses such as COPD and asthma. Furthermore, industry participants are aggressively investing in the introduction of technologically upgraded gadgets and software to fuel the growth of the spirometer market. Chronic obstructive pulmonary disease (COPD) is the third greatest cause of death. Certain illnesses can be treated more effectively if they are detected and diagnosed early. In this context, spirometry is a useful instrument since it helps to understand the severity of the infection and avoids misdiagnosis. The spirometer market is likely to expand throughout the forecast period as the prevalence of such respiratory illnesses rises. However, despite the worldwide prevalence of asthma and COPD, certain factors limit their use. A lack of skilled labor to conduct diagnostic tests is expected to limit market growth. COVID-19 Impact The COVID-19 outbreak had a negative impact on the global market because of a decrease in the diagnosis and treatment of respiratory diseases. Furthermore, the majority of pulmonary function tests (PFTs) labs and testing centers in potentially affected areas were closed. The pandemic also disrupted the global supply chain for medical devices. Browse key industry insights spread across 200 pages with 110 market data tables and figures & charts from the report on “ Global Spirometer Market  Size, Share, and COVID-19 Impact Analysis, By Product Type (Devices, Software, Accessories & Consumables), By Type (Volume Measurement, Peak Flow Meters), By Application (Chronic Obstructive Pulmonary Disorder (COPD), Asthma, Others), By End-User (Hospitals, Diagnostic Centers, Homecare Settings, Physician/Primary Care Offices or Clinics, Other Facilities) and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032.” Buy Now Full Report: The device segment is expected to hold the largest share of the global spirometer market during the forecast period. Based on the product type, the global spirometer market is classified into devices, software, accessories & consumables. Among these, the device segment is expected to hold the largest share of the spirometer market during the forecast period. The global market is experiencing significant technological advancements with the goal of improving testing capabilities, which has resulted in an increase in demand for advanced equipment. Furthermore, start-ups and major players began investing in the industry to develop devices for effective management of respiratory disorders, resulting in spirometer market growth The peak flow meters segment is witnessing significant CAGR growth over the forecast period. Based on the type, the spirometer market is segmented into volume measurement and peak flow meters. Among these, the peak flow meters segment is dominating the market with the largest revenue share over the forecast period. The device dominance is due to its ability to produce accurate results while remaining user-friendly. The volume measurement sector is expected to grow at a faster CAGR than peak flow meters over the forecast period, owing to the increasing use of the devices in asthma, cystic fibrosis, and other diseases. The chronic obstructive pulmonary disorder (COPD) segment is witnessing significant CAGR growth over the forecast period Based on application, the global spirometer market is segmented into chronic obstructive pulmonary disorder (COPD), asthma, and others. Among these, the chronic obstructive pulmonary disorder (COPD) segment is witnessing significant CAGR growth over the forecast period owing to the increasing incidence of pulmonary infection among patients. These devices are currently being tested in laboratories to determine whether they could be used to treat cystic fibrosis and other respiratory illnesses. This factor is expected to contribute to the expansion of the others section during the projection period. The hospitals segment is witnessing significant CAGR growth over the forecast period. Based on end-users, the global spirometer market is segmented into hospitals, diagnostic centers, homecare settings, physician/primary care offices or clinics, and other facilities. Among these, the hospitals segment is witnessing significant CAGR growth over the forecast period. Rising healthcare costs led to in the development of improved pulmonary function testing instruments, which have contributed to the segment growth during the forecast period. Inquire Before Buying This Research Report: North America dominates the market with the largest market share over the forecast period. North America is dominating the market share over the forecast period, owing to the growing prevalence of chronic respiratory disorders in the region, as well as the increasing acceptance of technologically advanced equipment, can be linked to the region's significant share of this market segment. The rising prevalence of COPD, asthma, and other respiratory illnesses can be attributed to this region's dominance. This has put additional financial crisis on the healthcare system, prompting the development of precision equipment to address the issue. The disease is putting a significant strain on the healthcare system. The disease's prevalence is expected to drive up demand for diagnostic devices. The increasing number of firms entering unexplored Asian economies, the Asia Pacific market is expected to grow at a significant CAGR during the forecast period. Furthermore, market participants in this region are investing significantly which is expected to drive spirometer market growth. Competitive Analysis: The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major vendors in the Global Spirometer market include Medical International Research (MIR), Morgan Scientific, COSMED srl, Ganshorn Medizin Electronic GmbH, ndd Medizintechnik AG, VYAIRE, MGC Diagnostics Corporation, nSpire Health Inc., Welch Allyn, Sibelmed, Schiller, SDI Diagnostics, Smiths Medical and among others. Get Discount At @ Recent Developments In January 2023, CAIRE Inc., a subsidiary of NGK SPARK PLUG CO., LTD., has acquired MGC Diagnostics Holdings, Inc. (MGC) to expand its portfolio of non-invasive cardiorespiratory diagnostics systems. MGC offers a diverse range of products, including pulmonary function testing systems, cardiopulmonary exercise systems, spirometers, flow sensors, gas analyzers, and associated consumables. In March 2023, Clario collaborated with technology startup ArtiQ to integrate its artificial intelligence (AI) into clinical trial data collection for spirometry. Market Segment This study forecasts revenue at global, regional, and country levels from 2022 to 2032. Spherical Insights has segmented the global spirometer market based on the below-mentioned segments: Spirometer Market, Product Type Analysis Devices Asthma Other Facilities

Welch Allyn Frequently Asked Questions (FAQ)

  • When was Welch Allyn founded?

    Welch Allyn was founded in 1915.

  • Where is Welch Allyn's headquarters?

    Welch Allyn's headquarters is located at 4341 State Street Road, Skaneateles Falls.

  • What is Welch Allyn's latest funding round?

    Welch Allyn's latest funding round is Incubator/Accelerator.

  • Who are the investors of Welch Allyn?

    Investors of Welch Allyn include ABHI US Accelerator and Hillrom.

  • Who are Welch Allyn's competitors?

    Competitors of Welch Allyn include Cupris and 1 more.


Compare Welch Allyn to Competitors


HealPros is a healthcare company focused on providing in-home care for individuals with chronic diseases. The company's main services include performing in-home diabetic retinal exams, health risk assessments, and management programs for diabetes and hypertension, as well as addressing social determinants of health such as food insecurity. HealPros primarily serves the healthcare industry, specifically targeting individuals with chronic illnesses. It is based in Atlanta, Georgia.

Intelligent Retinal Imaging Systems

Intelligent Retinal Imaging Systems is a company focused on the early detection of retinal pathologies, particularly in the healthcare sector. The company offers a cloud-based, camera-agnostic solution that aids healthcare providers in prioritizing diabetic eye care, by providing retinal screening software that helps capture, enhance, and diagnose diabetic retinopathy. The company primarily serves the healthcare industry, including health risk assessment companies, payors, and healthcare providers. It was founded in 2012 and is based in Pensacola, Florida.


RetInSight is a company focused on advancing ophthalmology through artificial intelligence solutions. The company offers AI-driven tools that assist eye care providers, academic institutions, and the eye care industry in diagnosing and managing diseases that manifest in the retina, such as Age-Related Macular Degeneration. RetInSight primarily serves the healthcare and academic sectors. It is based in Vienna, Austria.

Retina Labs Logo
Retina Labs

Retina Labs is a company focused on teleretinal screening for early detection of diabetic retinopathy in the healthcare sector. The company offers end-to-end diabetic retinopathy screening solutions for primary care practices and health systems, as well as comprehensive in-home preventive care screenings for health plans. Retina Labs primarily serves the healthcare industry, with a focus on primary care providers, health systems, and health plans. It was founded in 2004 and is based in Montreal, Quebec.

Cupris Logo

Cupris enables the remote examination of patients using smartphone-connected medical devices and a secure communication platform.


CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.